Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

The mechanisms involved in host clearance of symptomatic mucocutaneous herpes simplex virus (HSV) infection are unclear. We studied the functional properties of bulk cultures of skin-infiltrating lymphocytes from normal skin and serial biopsies of recurrent genital HSV-2 lesions, and compared HSV-specific and NK responses with viral clearance. HSV-specific CD4+ or CD8+ T cells were rarely detected in lymphocytes cultured from normal skin. The total lymphocyte count and HSV-specific and NK-like effector cell activities were markedly higher in cultures derived from lesional skin. HSV-specific CD4+ proliferative responses and NK-like cytotoxic responses were present at all stages of herpetic lesions, including biopsies early in the disease course. In contrast, cytotoxic T lymphocyte activity was generally low among cells derived from early culture-positive lesions, and increased during lesion evolution. Viral clearance from the lesion site was associated with a high level of local cytolytic activity towards HSV-infected cells. The phenotypes of cells with HSV-specific cytotoxic responses varied between patients, having CD4+ and CD8+ components. Immunotherapeutic approaches to HSV should be directed at improving in vivo cytolytic activity to HSV.

[1]  B. Roizman,et al.  Herpes simplex viruses: is a vaccine tenable? , 2002, The Journal of clinical investigation.

[2]  J. Tait,et al.  Herpes Simplex Virus Type 1 Renders Infected Cells Resistant to Cytotoxic T-Lymphocyte-Induced Apoptosis , 1998, Journal of Virology.

[3]  W. Kwok,et al.  Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201. , 1997, Human immunology.

[4]  Y. Miwa,et al.  Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells , 1997, Journal of virology.

[5]  L. Corey,et al.  High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes , 1996, Journal of virology.

[6]  P. Roth,et al.  Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood. , 1996, Tissue antigens.

[7]  S. Leng,et al.  Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. , 1996, Journal of immunology.

[8]  G. Nepom,et al.  HLA-DQB1 codon 57 is critical for peptide binding and recognition , 1996, The Journal of experimental medicine.

[9]  M. Brenner,et al.  Recognition and destruction of virus-infected cells by human gamma delta CTL. , 1994, Journal of immunology.

[10]  L. Corey,et al.  Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. , 1994, The Journal of infectious diseases.

[11]  S. Riddell,et al.  Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. , 1993, The Journal of clinical investigation.

[12]  Lawrence Corey,et al.  Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures , 1992 .

[13]  L. Corey,et al.  Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens , 1992, Journal of virology.

[14]  P. Fitzgerald-Bocarsly,et al.  Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts , 1991, Journal of virology.

[15]  M. Yasukawa,et al.  Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells. , 1989, Journal of immunology.

[16]  M. Yasukawa,et al.  Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus. , 1988, Journal of immunology.

[17]  R L Ashley,et al.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera , 1988, Journal of clinical microbiology.

[18]  S. Rosenberg,et al.  Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. , 1987, Journal of immunological methods.

[19]  L. Lanier,et al.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.

[20]  L. Lasky,et al.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. , 1986, Journal of immunology.

[21]  M. Yasukawa,et al.  Inhibition of herpes simplex virus replication in vitro by human cytotoxic T cell clones and natural killer cell clones. , 1985, The Journal of general virology.

[22]  L. Corey,et al.  Humoral immune response to HSV‐1 and HSV‐2 viral proteins in patients with primary genital herpes , 1985, Journal of medical virology.

[23]  T. Merigan,et al.  Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. , 1985, The Journal of general virology.

[24]  M. Yasukawa,et al.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. , 1984, Journal of immunology.

[25]  M. Yasukawa,et al.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. , 1984, Journal of immunology.

[26]  K. Holmes,et al.  Genital herpes simplex virus infections: clinical manifestations, course, and complications. , 1983, Annals of internal medicine.

[27]  G. Trinchieri,et al.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. , 1983, Journal of immunology.

[28]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[29]  E. Reinherz,et al.  Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. , 1982, Journal of immunology.

[30]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[31]  A. Wald Tests of statistical hypotheses concerning several parameters when the number of observations is large , 1943 .

[32]  W. V. Voorhis,et al.  Primary and secondary syphilis lesions contain mRNA for Th1 cytokines and activated cytolytic T cells , 1996 .

[33]  B. Rouse,et al.  Immunopathology of herpes simplex virus infections. , 1992, Current topics in microbiology and immunology.

[34]  B. Rouse,et al.  The role of T cell immunity in control of herpes simplex virus. , 1992, Current topics in microbiology and immunology.

[35]  R. Burke Contemporary approaches to vaccination against herpes simplex virus. , 1992, Current topics in microbiology and immunology.

[36]  B. Haynes Summary of T Cell Studies Performed during the Second International Workshop and Conference on Human Leukocyte Differentiation Antigens , 1986 .

[37]  T. Merigan,et al.  Evolution of recurrent herpes simplex lesions. An immunohistologic study. , 1985, The Journal of clinical investigation.

[38]  E. Petersen,et al.  Herpes simplex viruses. , 2009 .